The Larry J. Shapiro Director of the Institute for Public Health, William Powderly, MD, was national lead investigator of a clinical trial involving patients with severe COVID who were administered two anti-inflammatory drugs. Read more about the study’s findings.
Institute Director led study: Anti-inflammatory drugs did not speed COVID-19 recovery but prevented deaths (Links to an external site)
